Identification of novel mutations associated with cycloserine resistance in Mycobacterium tuberculosis-Reference-Cited by-同舟云学术

Identification of novel mutations associated with cycloserine resistance in Mycobacterium tuberculosis

Published:2017-09-12 Issue:12 Volume:72 Page:3272-3276
ISSN:0305-7453
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:

Author:

Chen Jiazhen¹,Zhang Shuo²,Cui Peng¹,Shi Wanliang²,Zhang Wenhong¹,Zhang Ying¹²

Affiliation:

1. Key Lab of Molecular Virology, Institute of Medical Microbiology, Department of Infectious Diseases, Huashan Hospital, Fudan University, Shanghai, China

2. Department of Molecular Microbiology and Immunology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA

Funder

NIH

Key Technologies Research and Development Program of China

National Natural Science Foundation of China

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Link

http://academic.oup.com/jac/article-pdf/72/12/3272/24332040/dkx316.pdf

Reference20 articles.

1. Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis;Caminero;Lancet Infect Dis,2010

2. Mechanism of d-cycloserine action: alanine racemase from Escherichia coli W;Lambert;J Bacteriol,1972

3. Structure of the Mycobacterium tuberculosisd-alanine:d-alanine ligase, a target of the antituberculosis drug d-cycloserine;Bruning;Antimicrob Agents Chemother,2011

4. Resistance to d-cycloserine in the tubercle bacilli: mutation rate and transport of alanine in parental cells and drug-resistant mutants;David;Appl Microbiol,1971

5. Roles of Mycobacterium smegmatisd-alanine:d-alanine ligase and d-alanine racemase in the mechanisms of action of and resistance to the peptidoglycan inhibitor d-cycloserine;Feng;Antimicrob Agents Chemother,2003

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Breaking barriers: The potential of nanosystems in antituberculosis therapy;Bioactive Materials;2024-09

2. Dual transcriptional inhibition of glutamate and alanine racemase is synergistic in Mycobacterium tuberculosis;Microbiology;2024-08-08

3. Discordance Between Phenotypic and WGS-Based Drug Susceptibility Testing Results for Some Anti-Tuberculosis Drugs: A Snapshot Study of Paired Mycobacterium tuberculosis Isolates with Small Genetic Distance;Infection and Drug Resistance;2024-08

4. Mechanisms of Mycobacterium tuberculosis Drug Resistance;Molecular Genetics, Microbiology and Virology;2024-03

5. Roles of Lipolytic enzymes in Mycobacterium tuberculosis pathogenesis;Frontiers in Microbiology;2024-01-29